Verrica Pharmaceuticals Inc. (VRCA) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

High Risk

Significant dilution risk

Last updated: March 11, 2026

Risk Assessment Details

Potential Dilution: 434.0% of current shares

Recent Dilution: 174.36% (2 years)

Historical Dilution Factor: significant recent dilution

Outstanding Shares

17M

Potential Supply

75M

Additional shares possible

Splits

None

Past 2 years

Summary

VRCA currently has 17.2M outstanding shares. with significant dilution risk as 74.6M authorized shares could dilute existing holders by 434.0%. The company has significantly diluted shareholders by 174.36% over the past 2 years, indicating aggressive capital raising.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
Mar 11, 2026	10-K filing \| 17.2M shares outstanding	17M	75M
Nov 14, 2025	10-Q filing \| 9.5M shares outstanding	9.5M	75M
Aug 12, 2025	10-Q filing \| 9.5M shares outstanding	9.5M	75M
May 13, 2025	10-Q filing \| 94.8M shares outstanding	95M	75M
Mar 11, 2025	10-K filing \| 91.8M shares outstanding	92M	75M
Mar 11, 2025	S-3 filing: The company is filing an S-3 to offer and sell up to $150,000,000 of any combination of common stock, preferred stock, debt securities and warrants.	51M	75M
Nov 05, 2024	10-Q filing \| 46.8M shares outstanding	47M	75M
Aug 14, 2024	10-Q filing \| 46.5M shares outstanding	47M	75M
May 13, 2024	10-Q filing \| 46.5M shares outstanding	46M	75M
Feb 29, 2024	10-K filing \| 45.3M shares outstanding	45M	75M
Nov 09, 2023	10-Q filing \| 46.1M shares outstanding	46M	75M
Aug 08, 2023	10-Q filing \| 45.9M shares outstanding	46M	75M
May 09, 2023	10-Q filing \| 43.0M shares outstanding	43M	75M
Mar 06, 2023	10-K filing \| 41.9M shares outstanding	42M	75M
Nov 07, 2022	10-Q filing \| 40.3M shares outstanding	40M	75M
Nov 07, 2022	S-3 filing: The company may offer and sell up to $150,000,000 of any combination of common stock, preferred stock, debt securities and warrants.	41M	75M
Aug 11, 2022	10-Q filing \| 41.1M shares outstanding	41M	12M
May 09, 2022	10-Q filing \| 27.5M shares outstanding	28M	12M
Mar 02, 2022	10-K filing \| 27.5M shares outstanding	28M	12M
Nov 12, 2021	10-Q filing \| 27.5M shares outstanding	28M	12M
Aug 10, 2021	10-Q filing \| 27.5M shares outstanding	28M	12M
May 07, 2021	10-Q filing \| 27.4M shares outstanding	27M	12M
Mar 17, 2021	10-K filing \| 25.4M shares outstanding	25M	12M
Nov 09, 2020	10-Q filing \| 25.9M shares outstanding	26M	12M
Aug 05, 2020	10-Q filing \| 25.8M shares outstanding	26M	12M
May 07, 2020	10-Q filing \| 25.8M shares outstanding	26M	12M
Mar 13, 2020	S-3 filing: The company may offer and sell up to $100,000,000 of any combination of common stock, preferred stock, and/or debt securities.	N/A	12M
Mar 13, 2020	10-K filing \| 25.8M shares outstanding	26M	12M

Back to VRCA Details